- Report
- January 2026
- 181 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- January 2026
- 181 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- November 2025
- 185 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- November 2025
- 182 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- November 2025
- 180 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- August 2025
- 188 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- June 2025
- 185 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- January 2026
- 117 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 132 Pages
Global
From €4147EUR$4,750USD£3,591GBP
- Report
- January 2026
- 120 Pages
Global
From €4147EUR$4,750USD£3,591GBP
- Report
- January 2026
- 284 Pages
Global
From €4147EUR$4,750USD£3,591GBP
- Report
- May 2025
- 164 Pages
Global
From €4147EUR$4,750USD£3,591GBP
- Report
- July 2025
- 350 Pages
Global
From €4321EUR$4,949USD£3,741GBP
- Report
- June 2025
- 400 Pages
Global
From €4321EUR$4,949USD£3,741GBP
- Report
- November 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,910GBP
€4235EUR$4,850USD£3,666GBP
- Report
- November 2025
- 190 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- September 2025
- 190 Pages
Global
From €4361EUR$4,995USD£3,776GBP
- Report
- January 2026
- 86 Pages
Global
From €3500EUR$4,294USD£3,136GBP
- Report
- March 2025
- 224 Pages
Global
From €3885EUR$4,450USD£3,364GBP
- Report
- November 2025
- 160 Pages
Global
From €3449EUR$3,950USD£2,986GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more